SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-092135
Filing Date
2016-01-19
Accepted
2016-01-19 17:12:08
Documents
1
Period of Report
2015-10-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 2230
  Complete submission text file 0001209191-16-092135.txt   3589
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Issuer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALEXZA PHARMACEUTICALS INC 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address
Oki Mark K (Reporting) CIK: 0001491847 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51820 | Film No.: 161348990